0000950103-16-018563.txt : 20161207
0000950103-16-018563.hdr.sgml : 20161207
20161207160930
ACCESSION NUMBER: 0000950103-16-018563
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20161207
DATE AS OF CHANGE: 20161207
EFFECTIVENESS DATE: 20161207
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Premier Pharma 1 LP
CENTRAL INDEX KEY: 0001691681
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-275824
FILM NUMBER: 162039185
BUSINESS ADDRESS:
STREET 1: C/O MORGAN STANLEY STRATEGIES II LLC
STREET 2: 522 FIFTH AVENUE, 13TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-296-6000
MAIL ADDRESS:
STREET 1: C/O MORGAN STANLEY STRATEGIES II LLC
STREET 2: 522 FIFTH AVENUE, 13TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
D
1
primary_doc.xml
X0707
D
LIVE
0001691681
Premier Pharma 1 LP
522 FIFTH AVENUE, 13TH FLOOR
NEW YORK
NY
NEW YORK
10036
212-296-6000
DELAWARE
Premier Private SPV 2 LP
None
Limited Partnership
true
2015
-
Morgan Stanley Strategies II LLC
522 FIFTH AVENUE, 13TH FLOOR
NEW YORK
NY
NEW YORK
10036
Executive Officer
General Partner of the Issuer
James
Bruno
c/o Morgan Stanley Smith Barney LLC
522 Fifth Avenue, 13th Floor
New York
NY
NEW YORK
10036
Director
Director of the General Partner
Jeremy
Beal
c/o Morgan Stanley Smith Barney LLC
522 Fifth Avenue, 13th Floor
New York
NY
NEW YORK
10036
Director
Director of the General Partner
Michael
Korn
c/o Morgan Stanley Smith Barney LLC
522 Fifth Avenue, 13th Floor
New York
NY
NEW YORK
10036
Director
Director of the General Partner
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
true
false
true
false
500000
Morgan Stanley Smith Barney LLC
149777
None
None
2000 WESTCHESTER AVENUE
PURCHASE
NY
NEW YORK
10577-2530
All States
false
Indefinite
0
Indefinite
false
0
0
0
0
false
Premier Pharma 1 LP
/s/ James Bruno
James Bruno
Director of the General Partner of the Issuer
2016-12-07